Neurology | Pharmacology Identification of inhibitors for neurodegenerative diseases targeting dual leucine zipper kinase through virtual screening and molecular dynamics simulations. June 10, 2024
Artificial Intelligence | Bioinformatics | Pharmacology Peptide-based drug discovery through artificial intelligence: towards an autonomous design of therapeutic peptides. June 10, 2024
Bioinformatics | Oncology | Pharmacology Potential inhibitors of VEGFR1, VEGFR2, and VEGFR3 developed through Deep Learning for the treatment of Cervical Cancer. June 10, 2024
Genetics | Pharmacology | Precision Medicine Prediction of adverse drug reactions due to genetic predisposition using deep neural networks. June 8, 2024
Drug Discovery | Pharmacology | Proteomics | Target Identification An end-to-end method for predicting compound-protein interactions based on simplified homogeneous graph convolutional network and pre-trained language model. June 7, 2024
Drug Discovery | Pharmacology Synergizing Chemical Structures and Bioassay Descriptions for Enhanced Molecular Property Prediction in Drug Discovery. June 5, 2024
Bioinformatics | Dermatology | Pharmacology A Top-Down Design Approach for Generating a Peptide PROTAC Drug Targeting Androgen Receptor for Androgenetic Alopecia Therapy. June 5, 2024
Alternative Medicine | Homeopathy | Pharmacology Vortex-like vs. turbulent mixing of a Viscum album preparation affects crystalline structures formed in dried droplets. June 5, 2024
Bioinformatics | Neurology | Pharmacology A novel framework based on explainable AI and genetic algorithms for designing neurological medicines. June 4, 2024
Bioinformatics | Drug Development | Pharmacology AI-based prediction of protein-ligand binding affinity and discovery of potential natural product inhibitors against ERK2. June 3, 2024
Biochemistry | Pharmacology Deep learning assisted logic gates for real-time identification of natural tetracycline antibiotics. May 31, 2024
Bioinformatics | Drug Discovery | Pharmacology FMCA-DTI: A Fragment-oriented method based on a Multihead Cross Attention mechanism to improve Drug-Target Interaction prediction. May 29, 2024